Get started
Author

Kathleen A. Bridges

Observed names: Kathleen Bridges, Second Author, Kathleen Bridges
OpenAlex ID: A5114004221
MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2011 · Kathleen A. Bridges, Hiroshi Hirai, et al. · Clinical Cancer Research · 237
PDF
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells
2014 · Kathleen A. Bridges, Carlo Toniatti, et al. · Oncotarget · 57
PDF
ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress
2009 · Adrienne N. Howard, Kathleen A. Bridges, et al. · Cancer Chemotherapy and Pharmacology · 39
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints
2020 · Jessica M. Molkentine, David P. Molkentine, et al. · International Journal of Radiation Biology · 38
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade
2021 · David P. Molkentine, Jessica M. Molkentine, et al. · Cancer Research · 37
PDF
Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer
2012 · Colin Brooks, Tommy Sheu, et al. · Radiation Oncology · 37
PDF
MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
2016 · Kathleen A. Bridges, Xingxing Chen, et al. · Oncotarget · 36
PDF
Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function
2021 · Manish Kumar, David Molkentine, et al. · Nature Communications · 32
PDF
Data from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
Data from p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade
2023 · David P. Molkentine, Jessica M. Molkentine, et al.
Supplementary Data from p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade
2023 · David P. Molkentine, Jessica M. Molkentine, et al.
PDF
Supplementary Data from p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade
2023 · David P. Molkentine, Jessica M. Molkentine, et al.
Supplementary Figure 6 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
PDF
Supplementary Figure 1 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
Supplementary Figure 2 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
PDF
Supplementary Figure 5 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
PDF
Supplementary Figure 3 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
PDF
Supplementary Figure Legends 1-6 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
Supplementary Figure 4 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
PDF
Data from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
Supplementary Figure 6 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
Supplementary Figure Legends 1-6 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
PDF
Supplementary Figure 5 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
Supplementary Figure 4 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
Supplementary Figure 1 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
2023 · Kathleen A. Bridges, Hiroshi Hirai, et al.
PDF
Works count: 38
Citation count: 514
H-index: 8
I10-index: 8
Year
Topic
Type